Paracetamol-AFT paracetamol 1000 mg/100 mL injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

paracetamol-aft paracetamol 1000 mg/100 ml injection vial

aft pharmaceuticals pty ltd - paracetamol, quantity: 10 mg/ml - injection, intravenous infusion - excipient ingredients: hydrochloric acid; cysteine hydrochloride monohydrate; dibasic sodium phosphate dihydrate; mannitol; nitrogen; water for injections; sodium hydroxide - paracetamol-aft 10mg/ml, solution for infusion is indicated for the relief of mild to moderate pain and the reduction of fever where an intravenous route of administration is considered clinically necessary.

Atenolol-AFT atenolol 50 mg/10 mL oral solution bottle Australia - English - Department of Health (Therapeutic Goods Administration)

atenolol-aft atenolol 50 mg/10 ml oral solution bottle

aft pharmaceuticals pty ltd - atenolol, quantity: 5 mg/ml - oral liquid, solution - excipient ingredients: propylene glycol; propyl hydroxybenzoate; saccharin sodium; purified water; citric acid monohydrate; sorbitol solution (70 per cent) (non-crystallising); sodium citrate dihydrate; methyl hydroxybenzoate; flavour - all grades of hypertension including hypertension of renal origin.,frequent disabling angina without evidence of cardiac failure,cardiac arrhythmias (acute treatment of supraventricular and ventricular arrhythmias including those with acute myocardial infarction),myocardial infarction - late intervention (beta-blocker class effect greater than 12 hours after onset of chest pain)

Burinex 1mg tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

burinex 1mg tablet blister pack

aft pharmaceuticals pty ltd - bumetanide, quantity: 1 mg - tablet, uncoated - excipient ingredients: agar; lactose monohydrate; maize starch; colloidal anhydrous silica; povidone; polysorbate 80; magnesium stearate; purified talc - burinex is indicated for the treatment of oedema, particularly that associated with congestive heart failure, hepatic and renal diseases including the nephrotic syndrome and acute pulmonary oedema.